Blood Collection, Processing, Management Devices & Consumables Global Market – Forecast To 2023

Publishing Date : January, 2017
Report Code : HCMD0142
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Blood collection, processing, management devices & consumables are class of medical devices used for collecting the whole blood from the donor, segregating the collected blood into blood components like RBC, WBC, platelets & plasma and then preserving the segregated components for the purpose of therapeutics and maintaining the protocols of available blood groups and donor information for serving the emergency purposes. These devices are mainly used for therapeutic and diagnostic medical application areas, where in therapeutic application the processed blood act as a lifesaving liquid organ. These blood collection, processing, management devices & consumables help in avoiding the transmission of infectious diseases and other complications during transfusion. 

Blood collection, processing, management devices & consumables market is segmented on the basis of applications, products, end-users and geography. In blood collection, processing, management devices & consumables market, applications market is further classified into diagnostics, therapeutics, research and others (transplantation compatibility tests and therapeutic drug effect monitoring), whereas diagnostics application market is further sub classified into infectious disease diagnosis, non infectious disease diagnosis, blood typing and others (doping, forensics and pregnancy tests), therapeutic applications are further segmented into hematology diseases, injury, trauma & surgeries and oncology. Products market is segmented into by devices, consumables, softwares and servicing, whereas devices are further classified into hematocrit centrifuges, blood grouping analyzers, blood coagulation analyzers, hematology analyzers, blood processors, blood warmers, blood bank refrigerators, blood bank freezers, slide stainer others. Consumables are subsegmented into blood administration sets, blood collection needles & syringes, blood collection tubes & microcollectors, blood lancets, blood filters, hematology reagents, blood bags, microscopic slides, vials, sedimentation tubes, blood grouping reagents, blood coagulation reagents, blood bags, blood filters, sedimentation tubes, hematology reagents, vials and others. By softwares are further segmented into hospital softwares and blood bank softwares. End-users are further classified into hospitals, diagnostic laboratories, academic & research laboratories, blood & blood component banks, ambulatory surgical center and others (biopharma & biotech companies and clinics).

Among the blood collection, processing, management devices & consumables product market, consumables segment holds the largest share and is expected to be the fastest growing segment from 2016 to 2023. In end-users, Hospitals are the largest segment and is the fastest growing segment from 2016 to 2023. Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the blood collection, processing, management devices & consumables market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The blood collection, processing, management devices & consumables market is expected to grow at a mid range single digit CAGR to reach $35,693 million by 2023. Increase in aging population and subsequent rise in incidence of chronic diseases, emergence of advanced automated blood collection and processing devices and favourable reimbursement policies are the factors driving the market growth. Emergence of needle free devices & RFID technology and market expansion opportunities in emerging countries are some of the opportunities of this market.

However various factors like patient safety risks due to chances of transmission of infectious diseases and lack of skilled professionals in handling automated processing devices limit the growth of blood collection, processing, management devices & consumables global market. The threats for the blood collection, processing, management devices & consumables market include soaring costs of blood handling devices and stringent government regulatory bodies guiding blood processing devices & consumables manufacturers.

The blood collection, processing, management devices & consumables global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Blood collection, processing, management devices & consumables market are Abbott Laboratories (U.S.), Becton Dickinson & Company  (U.S.), Haemonetics Corporation (U.S.), Grifols International S.A. (Spain), Immucor, Inc. (U.S.), Danaher Corporation (U.S.), Fresenius Kabi (U.K.), Sysmex Corporation (Japan), Terumo Corporation (Japan), Macopharma (France), ThermoFisher Scientific Corporation (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions and their sub regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN AGING POPULATION AND SUBSEQUENT RISE IN INCIDENCE OF CHRONIC DISEASES
        • 3.3.1.2     EMERGENCE OF ADVANCED AUTOMATED BLOOD COLLECTION & PROCESSING DEVICES
        • 3.3.1.3     FAVORABLE REIMBURSEMENT POLICIES
        • 3.3.1.4     EMERGENCE OF NEEDLE FREE DEVICES AND RFID TECHNOLOGY
        • 3.3.1.5     MARKET EXPANSION OPPORTUNITIES IN EMERGING NATIONS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     PATIENT SAFETY RISKS DUE TO CHANCES OF TRANSMISSION OF INFECTIONS AND INFECTIOUS DISEASES
        • 3.3.2.2     LACK OF SKILLED PROFESSIONALS IN HANDLING AUTOMATED PROCESSING DEVICES
        • 3.3.2.3     SOARING COST OF BLOOD PROCESSING DEVICES
        • 3.3.2.4     STRINGENT REGULATORY BODIES GUIDING THE BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MANUFACTURERS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     U.S.
      • 3.4.2     EUROPE
      • 3.4.3     INDIA
      • 3.4.4     CHINA
      • 3.4.5     JAPAN
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
    • 3.6     TECHNOLOGICAL ADVANCEMENTS
      • 3.6.1     AUTOMATED BLOOD COLLECTION & PROCESSING DEVICES
      • 3.6.2     PORTABLE BLOOD COLLECTION & PROCESSING DEVICES
      • 3.6.3     CUSTOMIZED BLOOD COLLECTION, PROCESSING DEVICES & CONSUMABLES
      • 3.6.4     HEMOSEP 3-D PRINTED BLOOD COLLECTION DEVICES
      • 3.6.5     MICROFLUIDIC BLOOD COLLECTION DEVICES
      • 3.6.6     RFID (RADIOFREQUENCY IDENTIFICATION) TECHNOLOGY
      • 3.6.7     ROBOTICS IN BLOOD COLLECTION & MANAGEMENT
    • 3.7     MANUAL V/S AUTOMATED BLOOD COLLECTION AND PROCESSING DEVICES
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     PORTER’S FIVE FORCE ANALYSIS
      • 3.9.1     THREAT OF NEW ENTRANTS
      • 3.9.2     THREAT OF SUBSTITUTES
      • 3.9.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.9.4     BARGAINING POWER OF SUPPLIERS
      • 3.9.5     BARGAINING POWER OF BUYERS
    • 3.10     MARKET SHARE ANALYSIS
  • 4     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     BY DEVICES
      • 4.2.1     HEMATOCRIT CENTRIFUGE
      • 4.2.2     BLOOD GROUPING ANALYZERS
      • 4.2.3     BLOOD COAGULATION ANALYZERS
      • 4.2.4     HEMATOLOGY ANALYZERS
      • 4.2.5     BLOOD CELL PROCESSORS
      • 4.2.6     BLOOD WARMERS
      • 4.2.7     BLOOD BANK REFRIGERATORS
      • 4.2.8     BLOOD BANK FREEZERS
      • 4.2.9     SLIDE STAINERS
      • 4.2.10     OTHERS
    • 4.3     CONSUMABLES
      • 4.3.1     BLOOD COLLECTION NEEDLE & SYRINGE
      • 4.3.2     BLOOD COLLECTION TUBES & MICROCOLLECTORS
      • 4.3.3     BLOOD LANCETS
      • 4.3.4     BLOOD BAGS
      • 4.3.5     BLOOD FILTERS
      • 4.3.6     SEDIMENTATION TUBES
      • 4.3.7     BLOOD COAGULATION REAGENTS
      • 4.3.8     BLOOD GROUPING REAGENTS
      • 4.3.9     HEMATOLOGY REAGENTS
      • 4.3.10     BLOOD ADMINISTRATION SETS
      • 4.3.11     BLOOD VIALS
      • 4.3.12     OTHERS
    • 4.4     MANAGEMENT SOFTWARES
      • 4.4.1     BLOOD BANK SOFTWARES
      • 4.4.2     HOSPITAL SOFTWARES
    • 4.5     SERVICING
  • 5     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     DIAGNOSTICS
      • 5.2.1     INFECTIOUS DISEASE DIAGNOSIS
      • 5.2.2     NON-INFECTIOUS DISEASE DIAGNOSIS
      • 5.2.3     BLOOD TYPING
      • 5.2.4     OTHERS
    • 5.3     THERAPEUTICS
      • 5.3.1     HAEMATOLOGY DISEASES
      • 5.3.2     INJURY, TRAUMA & SURGERY
      • 5.3.3     ONCOLOGY
    • 5.4     RESEARCH
    • 5.5     OTHERS
  • 6      BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     ACADEMIC INSTITUTES & RESEARCH LABORATORIES
    • 6.4     DIAGNOSTIC LABORATORIES
    • 6.5     AMBULATORY SURGICAL CENTERS
    • 6.6     BLOOD & BLOOD COMPONENT BANK
    • 6.7     OTHERS
  • 7     REGIONAL MARKET ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     FRANCE
      • 7.3.3     ITALY
      • 7.3.4     OTHERS
    • 7.4     ASIA PACIFIC
      • 7.4.1     INDIA
      • 7.4.2     CHINA
      • 7.4.3     JAPAN
      • 7.4.4     OTHERS
    • 7.5     REST OF THE WORLD (ROW)
      • 7.5.1     BRAZIL
      • 7.5.2     MIDDLE EAST
      • 7.5.3     OTHERS
  • 8     COMPANY DEVELOPMENTS
    • 8.1     INTRODUCTION
      • 8.1.1     APPROVAL AS A MAJOR GROWTH STRATEGY OF BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES PLAYERS
    • 8.2     APPROVALS
    • 8.3     NEW PRODUCT LAUNCH
    • 8.4     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
    • 8.5     OTHER DEVELOPMENTS
    • 8.6     MERGERS & ACQUISITIONS
  • 9     COMPANY PROFILES
    • 9.1     ABBOTT LABORATORIES, INC
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     BIO-RAD LABORATORIES
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     BIOMERIEUX
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     BECTON DICKINSON AND COMPANY
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     DANAHER CORPORATION (BECKMAN COULTER)
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY.
      • 9.5.6     SWOT ANALYSIS
    • 9.6     FRESENIUS KABI
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     GRIFOLS INTERNATIONAL SA
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     HAEMONETICS CORPORATION
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     IMMUCOR INC
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     MACOPHARMA
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS
    • 9.11     ROCHE DIAGNOSTICS
      • 9.11.1     OVERVIEW
      • 9.11.2     FINANCIALS
      • 9.11.3     PRODUCT PORTFOLIO
      • 9.11.4     KEY DEVELOPMENTS
      • 9.11.5     BUSINESS STRATEGY
      • 9.11.6     SWOT ANALYSIS
    • 9.12     SYSMEX CORPORATION
      • 9.12.1     OVERVIEW
      • 9.12.2     FINANCIALS
      • 9.12.3     PRODUCT PORTFOLIO
      • 9.12.4     KEY DEVELOPMENTS
      • 9.12.5     BUSINESS STRATEGY
      • 9.12.6     SWOT ANALYSIS
    • 9.13     TERUMO CORPORATION
      • 9.13.1     OVERVIEW
      • 9.13.2     FINANCIALS
      • 9.13.3     PRODUCT PORTFOLIO
      • 9.13.4     KEY DEVELOPMENTS
      • 9.13.5     BUSINESS STRATEGY
      • 9.13.6     SWOT ANALYSIS
    • 9.14     THERMO FISHER SCIENTIFIC, INC
      • 9.14.1     OVERVIEW
      • 9.14.2     FINANCIALS
      • 9.14.3     PRODUCT PORTFOLIO
      • 9.14.4     KEY DEVELOPMENTS
      • 9.14.5     BUSINESS STRATEGY
      • 9.14.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 2     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 3     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 4     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 5     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 6     BY DEVICES BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 7     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY DEVICES, (2015-2023) ($MN)
      • TABLE 8     HEMATOCRIT CENTRIFUGE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 9     BLOOD GROUPING ANALYZERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 10     BLOOD COAGULATION ANALYZER GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 11     HEMATOLOGY ANALYZER GLOBAL REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 12     BLOOD CELL PROCESSOR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 13     BLOOD WARMERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 14     BLOOD BANK REFRIGERATORS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 15     BLOOD BANK FREEZERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 16     SLIDE STAINERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 17     OTHERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 18     CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 19     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN)
      • TABLE 20     BLOOD COLLECTION NEEDLES & SYRINGES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 21     BLOOD COLLECTION TUBES & MICROCOLLECTORS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 22     BLOOD LANCETS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 23     BLOOD BAGS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 24     BLOOD FILTERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 25     SEDIMENTATION TUBES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 26     BLOOD COAGULATION REAGENTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 27     BLOOD GROUPING REAGENTS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 28     HEMATOLOGY REAGENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 29     BLOOD ADMINISTRATION SETS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 30     BLOOD VIALS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 31     OTHERS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 32     MANAGEMENT SOFTWARES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 33     MANAGEMENT SOFTWARES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 34     BLOOD BANK SOFTWARES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 35     HOSPITAL SOFTWARES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 36     SERVICING GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 37     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 38     DIAGNOSTIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 39     DIAGNOSTIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES APPLICATION MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 40     INFECTIOUS DISEASE DIAGNOSIS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 41     NON-INFECTIOUS DISEASE DIAGNOSIS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 42     BLOOD TYPING BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 43     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 44     THERAPEUTIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 45     THERAPEUTIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES APPLICATION MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 46     HEMATOLOGY DISORDERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 47     INJURY, TRAUMA & SURGERY BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 48     ONCOLOGY BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 49     RESEARCH BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 50     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 51     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 52     HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 53     ACADEMIC INSTITUTES & RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 54     DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 55     AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 56     BLOOD & BLOOD COMPONENTS BANK GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 57     OTHERS GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 58     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • TABLE 59     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 60     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES DIAGNOSTIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 61     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES THERAPEUTIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 62     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 63     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY DEVICES, (2015-2023) ($MN)
      • TABLE 64     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MANAGEMENT MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 65     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN)
      • TABLE 66     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 67     NORTH AMERICAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 68     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 69     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES DIAGNOSTIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 70     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES THERAPEUTIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 71     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 72     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY DEVICES, (2015-2023) ($MN)
      • TABLE 73     EUROPEAN BLOOD COLLECTION, PROCESSING,MANAGEMENT DEVICES & CONSUMABLES MANAGEMENT MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 74     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN)
      • TABLE 75     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 76     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 77     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 78     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES DIAGNOSTIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 79     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES THERAPEUTIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 80     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 81     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY DEVICES, (2015-2023) ($MN)
      • TABLE 82     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MANAGEMENT MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 83     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN)
      • TABLE 84     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 85     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 86     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY APPLICATIONS, (2015-2023) ($MN)
      • TABLE 87     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES DIAGNOSTIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 88     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES THERAPEUTIC MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 89     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 90     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY DEVICES, (2015-2023) ($MN)
      • TABLE 91     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MANAGEMENT MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 92     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY CONSUMABLES, (2015-2023) ($MN)
      • TABLE 93     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY END-USERS, (2015-2023) ($MN)
      • TABLE 94     REST OF THE WORLD BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 95     APPROVALS, (2014-2016)
      • TABLE 96     NEW PRODUCT LAUNCHES (2014-2016)
      • TABLE 97     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2014-2016)
      • TABLE 98     OTHER DEVELOPMENTS (2015)
      • TABLE 99     MERGERS AND ACQUISITIONS (2016)
      • TABLE 100     ABBOTT LABORATORIES, INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 101     ABBOTT LABORATORIES, INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 102     ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 103     BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 104     BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 105     BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 106     BIOMEREIUX: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 107     BIOMERIEUX: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 108     BIOMEREIUX: TOTAL REVENUE, BY CLINICAL SEGMENTS, (2014-2016) ($MN)
      • TABLE 109     BIOMEREIUX: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 110     BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 111     BECTON DIKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 112     BECTON DIKINSON AND COMPANY: TOTAL REVENUE, BY LIFESCIENCE SEGMENTS, (2014-2016) ($MN)
      • TABLE 113     BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 114     DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 115     DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 116     DANAHER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 117     FRESENIUS SE & CO: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 118     FRESENIUS SE & CO : TOTAL REVENUE, BY BUSINESS SEGMENTS, (2014-2016) ($MN)
      • TABLE 119     FRESENIUS KABI : TOTAL REVENUE, BY BUSINESS SEGMENTS, (2013-2015) ($MN)
      • TABLE 120     FRESENIUS KABI: TOTAL REVENUE, BY REGION (2013-2015) ($MN)
      • TABLE 121     GRIFOLS INTERNATIONAL S.A.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 122     GRIFOLS INTERNATIONAL S.A.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 123     GRIFOLS INTERNATIONAL S.A.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 124     HAEMONETICS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 125     HAEMONETICS CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 126     HAEMONETICS CORPORATION: TOTAL REVENUE, BY PRODUCT TYPE, (2013-2015) ($MN)
      • TABLE 127     HAEMONETICS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 128     IMMUCOR INC: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 129     IMMUCOR INC: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 130     IMMUCOR INC: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 131     ROCHE HOLDINGS AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 132     ROCHE HOLDINGS AG: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 133     SYSMEX CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 134     SYSMEX CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 135     SYSMEX CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 136     TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 137     TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 138     TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 139     THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 140     THERMO FISHER SCIENTIFIC, INC : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 141     THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE, BY GEOGRAPHY (2013-2015) ($MN)

      LIST OF FIGURES

      • FIGURE 1     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET SHARE AND REVENUE, BY REGION (2015-2023)
      • FIGURE 2     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET: RESEARCH APPROACH
      • FIGURE 3     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET: FORECASTING MODEL
      • FIGURE 5     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     MANUAL V’S AUTOMATED BLOOD COLLECTION, PROCESSING DEVICES GLOBAL MARKET SHARE, 2016 (%)
      • FIGURE 9     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET: PORTER’S ANALYSIS
      • FIGURE 11     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2016 (%)
      • FIGURE 12     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY PRODUCTS, (2016 V’S 2023) ($MN)
      • FIGURE 13     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES, PRODUCTS GLOBAL MARKET REVENUE, BY DEVICES, (2016 V’S 2023) ($MN)
      • FIGURE 14     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES, PRODUCT GLOBAL MARKET REVENUE, BY CONSUMABLES, (2016 V’S 2023) ($MN)
      • FIGURE 15     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES, MANAGEMENT SOFTWARES GLOBAL MARKET REVENUE, BY TYPE, (2016 V’S 2023) ($MN)
      • FIGURE 16     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 17     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES, DIAGNOSTIC APPLICATIONS GLOBAL MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 18     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES, THERAPEUTIC APPLICATIONS GLOBAL MARKET SHARE, BY TYPE, (2016 V’S 2023) (%)
      • FIGURE 19     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET REVENUE, BY END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 20     BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET SCENARIO, BY REGION, (2015 - 2023) ($MN) CAGR (%)
      • FIGURE 21     NORTH AMERICA BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, APPLICATIONS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 22     U.S. BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 23     U.S. BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 24     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 25     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 26     EUROPEAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, APPLICATIONS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 27     GERMANY BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 28     GERMANY BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 29     FRANCE BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 30     FRANCE BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 31     ITALY BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 32     ITALY BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 33     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 34     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 35     ASIA PACIFIC BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, APPLICATIONS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 36     INDIA BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 37     INDIA BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 38     CHINA BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 39     CHINA BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 40     JAPAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 41     JAPAN BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 42     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 43     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 44     ROW BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS, APPLICATIONS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 45     BRAZIL BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 46     BRAZIL BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 47     MIDDLE EAST BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 48     MIDDLE EAST BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 49     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET REVENUE, BY PRODUCTS & END-USERS, (2016 V’S 2023) ($MN)
      • FIGURE 50     OTHERS BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES MARKET SHARE, BY APPLICATIONS, (2016 V’S 2023) (%)
      • FIGURE 51     KEY GROWTH STRATEGIES, (2014-2016)
      • FIGURE 52     SWOT: ABBOTT LABORATORIES, INC
      • FIGURE 53     SWOT: BIO-RAD LABORATORIES
      • FIGURE 54     SWOT: BIOMEREIUX
      • FIGURE 55     SWOT: BECTON DICKINSON AND COMPANY
      • FIGURE 56     SWOT: DANAHER CORPORATION (BECKMAN COULTER)
      • FIGURE 57     SWOT: FRESENIUS KABI
      • FIGURE 58     SWOT: GRIFOLS INTERNATIONAL S.A.
      • FIGURE 59     SWOT: HAEMONETICS CORPORATION
      • FIGURE 60     SWOT: IMMUCOR, INC
      • FIGURE 61     SWOT: MACOPHARMA
      • FIGURE 62     SWOT: ROCHE DIAGNOSTICS
      • FIGURE 63     SWOT: SYSMEX CORPORATION
      • FIGURE 64     SWOT: TERUMO CORPORATION
      • FIGURE 65     SWOT: THERMO FISHER SCIENTIFIC, INC

      LIST OF COMPANIES MENTIONED IN REPORT

      • 1     3M
      • 2     A&T CORPORATION
      • 3     ABBOTT LABORATORIES
      • 4     ABLIANCE
      • 5     ACCRIVA DIAGNOSTICS
      • 6     ACCUBIOTECH CO LTD
      • 7     ACIME FRAME
      • 8     AGA SANITÄTSARTIKEL GMBH
      • 9     AJOSHA BIO TEKNIK PVT.LTD
      • 10     ALERE INC
      • 11     ALPHA LABORATORIES
      • 12     ALTAS MEDICAL
      • 13     AMERICORD
      • 14     ANALYTICON BIOTECHNOLOGIES AG
      • 15     ANGELANTONI LIFE SCIENCE S.R.L
      • 16     APEL CO
      • 17     ARKARY GROUP
      • 18     ASAHI KASEI MEDICAL CO LTD
      • 19     ASYNT LTD
      • 20     AVALUN
      • 21     AVIVA BIOSCIENCES
      • 22     AVON HEALTHCARE
      • 23     B BRAUN MELSUNGEN
      • 24     B MEDICAL SYSTEMS
      • 25     BARKEY
      • 26     BECTON AND DICKINSON COMPANY
      • 27     BEHNK ELEKTRONIK
      • 28     BEURER GMBH
      • 29     BIO GROUP MEDICAL SYSTEM S.R.L.
      • 30     BIOBASE
      • 31     BIODEX MEDICAL SYSTEMS INC
      • 32     BIOE
      • 33     BIOELECTTRONICA S.R.L.
      • 34     BIOLABO S.A.S.
      • 35     BIOMERIEUX
      • 36     BIOPLUS
      • 37     BIO-RAD LABORATORIES
      • 38     BIOSAFE GROUP
      • 39     BIOSIGMA
      • 40     BIOSYSTEMS S.A
      • 41     BIOTEC
      • 42     BIRLAMEDISOFT PVT LTD
      • 43     BLOOD BANK COMPUTER SYSTEMS
      • 44     BOEKEL SCIENTIFIC
      • 45     BOULE DIAGNOSTICS AB
      • 46     BPC BIOSED S.R.L
      • 47     BRANDT INDUSTRIES INC
      • 48     BULGIN
      • 49     CARDIAL HEALTH
      • 50     CARETIUM MEDICAL INSTRUMENTS CO LIMITED
      • 51     CAVALLO SRL
      • 52     CELLIX LTD
      • 53     CENTRON CORPORATION
      • 54     CERUS CORPORATION
      • 55     CERNER CORPORATION
      • 56     CESCA THERAPEUTICS INC
      • 57     CIFTECH SOLUTIONS PVT. LTD
      • 58     CLINDIAG SYSTEMS B.V.B.A
      • 59     CLINTRON INDUSTRIES INC
      • 60     CONVERGENT TECHNOLOGIES
      • 61     COPAN
      • 62     CYPRESS DIAGNOSTICS
      • 63     DANAHER CORPORATION
      • 64     DEEPEE COOLING PRODUCTS PVT LTD
      • 65     DELCON S.R.L.
      • 66     DIAGAST
      • 67     DIAGON
      • 68     DIALAB
      • 69     DIATRON MI PLC
      • 70     DICONEX
      • 71     DYMIND BIOTECH
      • 72     ELECKTRO-MAG
      • 73     ELITECH GROUP
      • 74     EMSAŞ ELEKTRIK MALZEMELERI
      • 75     ERBA DIAGNOSTICS MANNHEIM GMBH
      • 76     ESTILL MEDICAL TECHNOLOGIES INC
      • 77     EUROCLINIC
      • 78     EUROLYSER DIAGNOSTICA
      • 79     EVERMED S R L
      • 80     EXTHERA MEDICAL CORPORATION
      • 81     FENNER PLC
      • 82     FIOCCHETTI
      • 83     FL MEDICAL S.R.L.
      • 84     FRESENIUS KABI
      • 85     GENESIS BPS
      • 86     GENRUI
      • 87     GOLDWIN MEDICARE LTD
      • 88     GOOGLE
      • 89     GREINER BIO-ONE
      • 90     GRIFOLS INTERNATIONAL S.A.
      • 91     GSG ROBOTIX
      • 92     HAEMONETICS
      • 93     HAEMOTEC
      • 94     HAEMATOLOGIC TECHNOLOGIES, INC
      • 95     HAIER
      • 96     HAMILTON
      • 97     HARDY DIAGNOSTICS
      • 98     HEALTHCARE ID INC
      • 99     HEBEI PUKANG MEDICAL INSTRUMENTS CO LTD
      • 100     HEINZ HERENZ MEDIZINALBEDARF GMBH
      • 101     HELENA BIOSCIENCES EUROPE
      • 102     HELENA LABORATORIES
      • 103     HELMER SCIENTIFIC
      • 104     HENIZ HERENZ MEDIZINALBEDARF GMBH
      • 105     HEROLAB GMBH
      • 106     HESKA
      • 107     HETECH
      • 108     HETTICH GMBH & CO KG
      • 109     HIDEMAR
      • 110     HISTO-LINE LABORATORIES S.R. L.
      • 111     HORIBA MEDICAL
      • 112     HOSPITEX DIAGNOSTICS
      • 113     HTL-STREFA
      • 114     HTZ
      • 115     HYCEL HANDELSGESELSCHAFT M.B.H.
      • 116     IMMOCLINIC
      • 117     INFOMED
      • 118     INNVOL MEDICAL SYSTEMS
      • 119     INSIGNIA INTERNATIONAL
      • 120     INSTRUMENTATION LABORATORY
      • 121     INTEGRATED MEDICAL SYSTEMS
      • 122     IT SYNERGISTICS
      • 123     JIANGSU HUIDA MEDICAL INSTRUMENTS CO LTD
      • 124     JMS CORPORATION
      • 125     JOHNSON & JOHNSON
      • 126     KANEKA CORPORATION
      • 127     KAWASUMI LABORATORIES INC
      • 128     KEEWELL MEDICAL TECHNOLOGIES
      • 129     KW APPARECCHI SCIENTIFICI
      • 130     LABCOLD
      • 131     LABNET INTERNATIONAL
      • 132     LABTOP INSTRUMENTS PVT LTD
      • 133     LEMI GROUP
      • 134     LEPU MEDICAL TECHNOLOGY
      • 135     LIFESCAN
      • 136     LMB TECHNOLOGIES GMBH
      • 137     LORNE LABORATORIES LTD
      • 138     MACCURA BIOTECHNOLOGY CO LTD
      • 139     MACOPHARMA
      • 140     MAGNOLIA MEDICAL TECHNOLOGIES
      • 141     MAK SYSTEM
      • 142     MEDICA CORPORATION
      • 143     MEDICON HELLAS S.A.
      • 144     MEDITECH TECHNOLOGIES INDIA PRIVATE LIMITED
      • 145     MEDIWARE INFORMATION SYSTEM INC
      • 146     MEDTRONIC
      • 147     MERIL LIFE SCIENCES
      • 148     MICRO LAB INSTRUMENTS
      • 149     MICROCULUS
      • 150     MICROPOINT BIOSCIENCE INC
      • 151     MINDRAY MEDICAL INTERNATIONAL LTD
      • 152     MOLLER MEDICAL GMBH & CO KG
      • 153     NANNING PASSION MEDICAL EQUIPMENT
      • 154     NIHON KOHDEN CORPORATION
      • 155     NIPRO DIAGNOSTICS
      • 156     NUOVA APTACA SRL
      • 157     NUVE SANAYI MALZEMELERI İMALAT VE TICARET A.S.
      • 158     OLYMPUS CORPORATION
      • 159     ORTHO CLINICAL DIAGNOSTICS
      • 160     PANASONIC
      • 161     PERLONG MEDICAL EQUIPMENT CO LTD
      • 162     PFIZER INC
      • 163     PHILLIP KRISCH GMBH
      • 164     PHOENIX INSTRUMENT
      • 165     PIXCELL MEDICAL
      • 166     PLASTILAB
      • 167     PLINTH 2000
      • 168     POLYMED MEDICAL DEVICES
      • 169     PSILIAKOS LTD
      • 170     PZ CORMAY
      • 171     QED SCIENTIFIC LIMITED
      • 172     Q-SERA’S PVT LTD
      • 173     QUOTIENT TECHNOLOGY INC
      • 174     R.S.SCIENTIFIC
      • 175     RANDOX LABORATORIES LTD
      • 176     RAPID LABS LTD
      • 177     RAYTO LIFE AND ANALYTICAL SCIENCES
      • 178     REMI LABORATORY INSTRUMENTS
      • 179     ROBONIK
      • 180     ROCHE HOLDINGS AG
      • 181     ROEMER INDUSTRIES
      • 182     ROMSONS SCIENTIFIC & SURGICAL PVT. LTD
      • 183     SAILBOAT LAB CO LTD
      • 184     SALADAX BIOMEDICAL INC
      • 185     SANQUIN
      • 186     SANTEMOL GROUP MEDIKAL
      • 187     SARSTEDT
      • 188     SCC SOFT COMPUTER
      • 189     SCILOGEX LLC
      • 190     SEERS MEDICAL
      • 191     SEKISUI MEDICAL CO LTD
      • 192     SEVENTH SENSE BIOSYSTEMS INC
      • 193     SFRI MEDICAL DIAGNOSTICS
      • 194     SHANGHAI PINXING MEDICAL EQUIPMENT CO LTD
      • 195     SHANGHAI SANCH MEDICAL INSTRUMENT CO LTD
      • 196     SHENZHEN BESTMAN INSTRUMENT CO LTD
      • 197     SHENZHEN BOOMINGSHING MEDICAL DEVICE
      • 198     SHENZHEN PROKAN ELECTRONICS INC
      • 199     SIEMENS HEALTHINEERS
      • 200     SINGULEX INC
      • 201     SISU GLOBAL HEALTH
      • 202     SLAMED ING GMBH
      • 203     SPINREACT
      • 204     SPOT ON SCIENCES
      • 205     STAGO
      • 206     STRATASYS
      • 207     STRIDE SOFTWARE SOLUTIONS
      • 208     SUNOSTIK MEDICAL TECHNOLOGY
      • 209     SUNQUEST INFORMATION SYSTEMS
      • 210     SUZHOU HYBIOME BIOMEDICAL ENGINEERING CO. LTD
      • 211     SYNGEN
      • 212     SYSMEX CORPORATION
      • 213     TARSUS MEDICAL INC
      • 214     TASSO INC
      • 215     TBS GROUP S.P.A.
      • 216     TECNODENT S.R.L
      • 217     TECO MEDICAL INSTRUMENTS
      • 218     TELSTAR LIFE SCIENCE SOLUTIONS
      • 219     TENKO INTERNATIONAL GROUP
      • 220     TERUMO CORPORATION
      • 221     THALHEIMER KÜHLUNG GMBH
      • 222     THERMO FISHER SCIENTIFIC INC
      • 223     TITANOX S.R.L.
      • 224     TOKRA MEDIKAL
      • 225     TOMOS LIFE SCIENCE GROUP
      • 226     TRIDEMA ENGINEERING S.R.L.
      • 227     TRITEC
      • 228     URIT MEDICAL ELECTRONIC GROUP CO LTD
      • 229     VASINI STRUMENTI S.R.L
      • 230     VEEBOT LLC
      • 231     VELANO VASCULAR
      • 232     VISIOMED
      • 233     VISION SCIENTIFIC
      • 234     VITLAB GMBH
      • 235     VOGT MEDICAL
      • 236     WAMA DIAGNOSTICA
      • 237     WERKSITZ GMBH
      • 238     YANCHENG CORDIAL CO LTD